4.7 Article

lncRNA NEAT1 promotes autophagy of neurons in mice by impairing miR-107-5p

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Inhibitory effect of mitoquinone against the α-synuclein fibrillation and relevant neurotoxicity: possible role in inhibition of Parkinson's disease

Gege Yu et al.

Summary: The study demonstrated that MitoQ can inhibit the formation of alpha-synuclein fibrillation products by modulating aggregation pathways and kinetic parameters, while also reducing neurotoxic effects against SH-SY5Y cells in aged alpha-synuclein samples. Co-incubation of alpha-synuclein with MitoQ resulted in less membrane leakage, oxidative and nitro-oxidative stress, macromolecular modifications, and apoptosis.

BIOLOGICAL CHEMISTRY (2022)

Article Neurosciences

Mechanism of miR-132-3p Promoting Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson's Disease

Xin Gong et al.

Summary: This study aims to investigate the effect and mechanism of miR-132-3p in regulating neuroinflammation and dopaminergic neuron degeneration in Parkinson's disease (PD). The results showed elevated expression of miR-132-3p and decreased expression of GLRX in PD patients and cell models. Overexpression of miR-132-3p induced activation of microglial cells, which could be reversed by GLRX overexpression.

ENEURO (2022)

Article Biochemistry & Molecular Biology

NEAT1 Decreasing Suppresses Parkinson's Disease Progression via Acting as miR-1301-3p Sponge

Qiang Sun et al.

Summary: Our study demonstrated that decreasing NEAT1 effectively suppressed MPP+-induced neuronal apoptosis. Mechanistically, downregulation of NEAT1 repressed alpha-syn-induced activation of NLRP3 inflammasome via inhibiting the expression of GJB1 by targeting miR-1301-3p. This provides new evidence for lncRNA NEAT1 as a potential therapeutic target for Parkinson's disease.

JOURNAL OF MOLECULAR NEUROSCIENCE (2021)

Article Biochemistry & Molecular Biology

Robust Dopaminergic Differentiation and Enhanced LPS-Induced Neuroinflammatory Response in Serum-Deprived Human SH-SY5Y Cells: Implication for Parkinson's Disease

Aram Niaz et al.

Summary: Neuroinflammation may play a pivotal role in the onset and progression of Parkinson's disease, but suitable cellular models and biomarkers for detecting early signs of neuroinflammation are currently lacking.

JOURNAL OF MOLECULAR NEUROSCIENCE (2021)

Article Immunology

Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson's disease via gut microbiota-GLP-1 pathway

Jing Sun et al.

Summary: The study suggests that the probiotic Clostridium butyricum (Cb) has neuroprotective effects on Parkinson's disease (PD) by improving abnormal gut microbiota-gut-brain axis. This intervention could potentially reverse motor deficits, dopaminergic neuron loss, synaptic dysfunction, and microglia activation in PD, providing a new insight into treating PD through gut microbiota modulation.

BRAIN BEHAVIOR AND IMMUNITY (2021)

Article Cell Biology

LncRNA HOTAIR Promotes Neuronal Damage Through Facilitating NLRP3 Mediated-Pyroptosis Activation in Parkinson's Disease via Regulation of miR-326/ELAVL1 Axis

Qian Zhang et al.

Summary: In Parkinson's disease, HOTAIR positively regulates NLRP3-mediated pyroptosis activation through the miR-326/ELAVL1 axis, which significantly inhibits neuronal damage and may contribute to a better understanding of PD pathogenesis and provide new treatment strategies for the disease.

CELLULAR AND MOLECULAR NEUROBIOLOGY (2021)

Article Biochemistry & Molecular Biology

Targeting mitophagy in Parkinson's disease

Emily H. Clark et al.

Summary: The genetics and pathophysiology of Parkinson's disease strongly implicate mitochondria in disease development, with defects in mitophagy potentially playing a role in pathogenesis. Pharmacological enhancement of mitophagy is a promising therapeutic approach, but the full therapeutic potential of targeting mitophagy pathways requires further exploration.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

LncRNA NEAT1 Regulates the Development of Parkinson's Disease by Targeting AXIN1 Via Sponging miR-212-3p

Tao Liu et al.

Summary: NEAT1 is highly expressed in PD, and knockdown of NEAT1 can promote cell viability and suppress PD progression through the miR-212-3p/AXIN1 pathway.

NEUROCHEMICAL RESEARCH (2021)

Review Neurosciences

NEAT1 on the Field of Parkinson's Disease: Offense, Defense, or a Player on the Bench?

Fanni Annamaria Boros et al.

Summary: Parkinson's disease is the second most common neurodegenerative disease globally, and there is a need to identify biomarkers and new therapeutic targets. NEAT1 has emerged as a possible regulatory hub in PD development, but its exact role is still debated. The contradictory findings of NEAT1's involvement in PD highlight the complexity of neurodegenerative disorders and the limitations of disease models, calling for further research to clarify its potential as a biomarker and therapeutic target.

JOURNAL OF PARKINSONS DISEASE (2021)

Article Biochemistry & Molecular Biology

lncRNA NEAT1 prompts autophagy and apoptosis in MPTP-induced Parkinson's disease by impairing miR-374c-5p

L. Dong et al.

Summary: The study found that NEAT1 levels were significantly correlated with MPTP-induced Parkinson's disease (PD) mice, dopamine neurons, and cells treated with MPP+, and that NEAT1 inhibition effectively promoted cell proliferation, inhibited apoptosis and autophagy. Silencing NEAT1 increased the TH+ rate of neurons and greatly suppressed autophagy. Additionally, NEAT1 may impact apoptosis and autophagy of SH-SY5Y cells through miR-374c-5p.

ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2021)

Article Biotechnology & Applied Microbiology

Long non-coding RNA nuclear enriched abundant transcript 1 (NEAT1) sponges microRNA-124-3p to up-regulate phosphodiesterase 4B (PDE4B) to accelerate the progression of Parkinson's disease

Ming-Yu Chen et al.

Summary: The study demonstrated that depletion of NEAT1 in Parkinson's disease cell models increased cell viability, reduced cell injury and inflammatory response by regulating the expression levels of miR-124-3p and PDE4B. NEAT1 was identified as a promising target for treating PD.

BIOENGINEERED (2021)

Article Clinical Neurology

Endocannabinoid levels in patients with Parkinson's disease with and without levodopa-induced dyskinesias

Camila Marchioni et al.

JOURNAL OF NEURAL TRANSMISSION (2020)

Article Integrative & Complementary Medicine

Neuroprotective effects of Danshensu on rotenone-induced Parkinson's disease models in vitro and in vivo

Tian Wang et al.

BMC COMPLEMENTARY MEDICINE AND THERAPIES (2020)

Review Biochemistry & Molecular Biology

Parkinson's disease biomarkers based on α-synuclein

Muneera Fayyad et al.

JOURNAL OF NEUROCHEMISTRY (2019)

Review Neurosciences

Autophagy in Traumatic Brain Injury: A New Target for Therapeutic Intervention

Li Zhang et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)

Article Biotechnology & Applied Microbiology

LincRNA-p21 Inhibits Cell Viability and Promotes Cell Apoptosis in Parkinson's Disease through Activating -Synuclein Expression

Xiaonan Xu et al.

BIOMED RESEARCH INTERNATIONAL (2018)